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Abstract
Background: Effective implementation strategies are needed to optimize advancements in the fields of cancer
diagnosis, treatment, survivorship, and end-of-life care. We conducted a review of systematic reviews to better
understand the evidentiary base of implementation strategies in cancer control.
Methods: Using three databases, we conducted a search and identified English-language systematic reviews
published between 2005 and 2010 that targeted consumer, professional, organizational, regulatory, or financial
interventions, tested exclusively or partially in a cancer context (primary focus); generic or non-cancer-specific
reviews were also considered. Data were extracted, appraised, and analyzed by members of the research team, and
research ideas to advance the field were proposed.
Results: Thirty-four systematic reviews providing 41 summaries of evidence on 19 unique interventions comprised
the evidence base. AMSTAR quality ratings ranged between 2 and 10. Team members rated most of the
interventions as promising and in need of further research, and 64 research ideas were identified.
Conclusions: While many interventions show promise of effectiveness in the cancer-control context, few reviews
were able to conclude definitively in favor of or against a specific intervention. We discuss the complexity of
implementation research and offer suggestions to advance the science in this area.
Background
Innovations in screening and early detection, develop-
ment of effective treatment interventions, and strategies
to improve quality of life have emerged from primary
studies, and systematic reviews of these studies, in can-
cer control [1-9]. These advancements have the capacity
to reduce mortality and morbidity from disease. How-
ever, optimizing these advancements requires their
appropriate application, a goal that is often difficult to
achieve [10,11]. Understanding what are the most effec-
tive and promising interventions is warranted to ensure
that the appropriate options are chosen and incorpo-
rated into implementation plans and prioritized for
future research studies. The analysis of studies examin-
ing the effectiveness of implementation interventions is
a key component to an overall knowledge translation
(KT) research agenda [12].
The purpose of our study was to conduct a review of
systematic reviews to better understand the evidentiary
foundation regarding what is known about KT interven-
tions. Specifically, we wanted to better understand the
strengths and limitations of the field, to identify what
interventions are ready for use now, and to identify
research priorities and directions for the future. We
were interested in studies conducted in the context of
cancer control across the care continuum, from diag-
noses to survivorship and end-of-life care, and across
cancer diagnoses. We chose this scope given that “con-
text” has been identified as an important consideration
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and is a concept central to several KT models and
research paradigms [12-15].
Methods
Overview
This project, Knowledge Translation to Improve Cancer
Control in Canada, was funded by the Ontario Institute
for Cancer Research and the Canadian Partnership
Against Cancer. It received ethics approval from the
Hamilton Health Sciences/Faculty of Health Sciences
Research Ethics Board, McMaster University, Hamilton,
Ontario, Canada. The design,e x e c u t i o n ,a n a l y s i s ,a n d
reporting of the project was editorially independent
from the funders.
To avoid duplication of effort, and to complete the
study in the required time, we capitalized on available
high-quality databases profiling systematic reviews of
interventions to systematically search for, appraise, and
evaluate the effectiveness of KT interventions that met
our inclusion criteria. Aligning with existing categorical
schemes (Canadian Agency for Drugs and Technologies
in Health [CADTH] and Cochrane Collaboration’s
Effective Practice and Organisation of Care [EPOC]
group), we sought interventions that targeted the group-
ings of consumers/patients/public (i.e.,c o n s u m e ri n t e r -
ventions), clinicians and healthcare providers (i.e.,
professional interventions), organizational/managers/sys-
tem leaders (i.e., organizational interventions), regulatory
(i.e., new health service delivery regulation), and finan-
cial (i.e., incentives).
Search
To identify existing systematic reviews that met our
inclusion criteria, we used three databases as our
sources:
1. Rx for Change (CADTH-EPOC Group Collabora-
tive Initiative): http://www.cadth.ca/en/resources/rx-for-
change/database
2. Health Systems Evidence (formerly, Program in Pol-
icy Decision-Making), McMaster University: http://www.
healthsystemsevidence.org/
3. McMaster KT+, McMaster University: http://plus.
mcmaster.ca/kt/Default.aspx
Eligibility criteria
Inclusion criteria
￿ Study designs: Systematic reviews published between
2005 and 2010. While the methodology is still evolving,
this interval was chosen to align with best evidence sug-
gesting median survival time of a systematic review is
approximately five years [16].
￿ Outcomes: Systematic reviews that included at least
one of the following outcomes: measurable clinical
outcomes, observable behavior change, documented
intention to behave, documented attitudes, documen-
ted knowledge uptake, or reported stakeholder
satisfaction.
￿ KT interventions: Interventions that focused on at
least one of the following target groupings: consumer,
professional, organization, regulatory, and financial, as
outlined in the CADTH-EPOC framework.
￿ Clinical scenarios:
○ Diagnosis: Interventions that were tested in can-
cer-specific environments (any cancer diagnosis).
Reviews that included cancer as part of the clinical
context or that were generic/nonspecific to clinical
condition were also considered.
○ Stage of continuum of care: Diagnosis, treatment,
follow-up, survivorship, end-of-life [17]
a.
Exclusion criteria
￿ Study designs: Any design other than systematic
reviews.
￿ Language: Non-English language due to cost and
availability of translations.
Data extraction
Data were extracted from the systematic reviews meet-
ing our eligibility criteria. For all reviews, data
extracted included (i) intervention name/label; (ii)
intervention definition and purpose; (iii) theories, fra-
meworks, or models used to inform the design or
execution of the intervention; (iv) key operational ele-
ments underpinning the execution of the intervention;
(v) setting; (vi) geography (where the intervention was
tested); (vii) stakeholder involvement (who and type of
involvement); (viii) evaluation strategy; (ix) measure-
ment instrument(s); (x) quality indicators and out-
comes; (xi) recommendations and conclusions; (xii)
cost information and/or information regarding sustain-
ability of the intervention; and (xiii) AMSTAR quality
appraisal (if available).
Quality control and critical appraisal
Title, abstract, and full-text screenings were done in
duplicate (KG and LD). Disagreements were resolved by
consensus or by a third party (JM). Data extraction and
critical appraisal (if required) were conducted by one
researcher and audited by a second. In circumstances
where appraisal was not completed by the original
source, the systematic reviews were appraised using
AMSTAR [18], an 11-item evaluation tool assessing
methodological standards, presentation, and critical
appraisal in systematic reviews. AMSTAR ratings can
range between 1 and 11, with 11 denoting highest
quality.
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priorities/direction
Data tables describing the systematic review study char-
acteristics and results were circulated to subgroups of
the research team (see Additional File 1). For each
assigned systematic review and using a 7-point scale,
members of the subgroups were asked to indicate their
“assessment of effectiveness” for each intervention
reviewed based on their interpretation of the data. A
rubric was designed to guide these assessments and the
interpretation of the rating scale. Interventions rated
between 1 and 3 were considered ineffective, interven-
t i o n sr a t e d4a n d5w e r ec o n s i d e r e dp r o m i s i n ga n d
worth additional investigation, and interventions rated 6
or 7 were considered effective. Average scores of ratings
were calculated for each systematic review. Investigators
were then asked to identify any specific research priori-
ties or research questions they thought relevant.
Results
Overall
The initial search for systematic reviews yielded 591
reviews for consideration from the three source data-
bases. Of these, a total of 38 reviews were originally
considered and 31 retained [19]
b. An additional three
reviews were included post hoc, identified by members
of the research team (see Additional File 2).
In total, 34 unique systematic review publications pro-
viding 41 evidence summaries on 19 unique interven-
tions comprised the evidence base. Table 1 provides the
definitions of the interventions considered. Some sys-
tematic reviews addressed more than one intervention
or provided more than one evidence summary; in addi-
tion, more than one systematic review was available for
some of the interventions. Additional File 2 provides the
references for the included systematic reviews.
The overall quality of the systematic reviews, as mea-
sured by the AMSTAR tool [18], was moderate. The
systematic reviews were most apt to target the treatment
stage of the continuum and least likely to target survi-
vorship (Table 2). Further, despite being a highly preva-
lent disease site, few systematic reviews targeted patients
with lung cancer (Table 3). Some less prevalent diag-
noses (head and neck, sarcoma, and melanoma) were
rarely or never targeted. A significant number of reviews
did not specify cancer diagnosis.
With respect to characteristics of the systematic
reviews (Table 4), most did not specify whether a KT
theory, model or framework was used to inform the
design of the project or the intervention itself. Most of
the reviews used a mixture of study designs as their pri-
mary evidentiary source, and only four reviews used
non-randomized controlled trial (RCT) data exclusively
as their primary evidence. Most systematic review
authors reported poorly executed and poorly reported
primary studies.
Common outcomes reported in the literature were
measures of knowledge, satisfaction, and observed beha-
vior and, to a lesser extent, clinical outcomes. Indeed, 7
of 17 consumer evidence summaries reported clinical
outcomes, while 12 reported on knowledge, 10 reported
on behavior observed, 9 reported on satisfaction, 8
reported on behavior intention, and 6 reported on atti-
tude. For professional evidence summaries, 11 of 14
reported clinical outcomes, compared to knowledge (2),
satisfaction (2), and behavior observed (10). Similarly,
the most reported outcome for organizational evidence
summaries were clinical outcomes (8), compared to
behavior observed (7), satisfaction (7), knowledge (4),
attitude (2), and behavior intention (1). However, when
considering across the 41 evidence summaries in our
sample, only 15 of 41 reported clinical outcomes.
With respect to intervention context (Table 5), clini-
cians were most often delivering the intervention, and a
clinical environment (e.g.,c l i n i c s ,h o s p i t a l s )w a st h e
most common setting for the intervention to take place.
Interventions were most often delivered in person, by
paper, or by phone. Technology-based modalities were
used less often unless they defined the intervention itself
(e.g., electronic medical record, clinical decision support
systems).
The following sections, including the tables and addi-
tional files, provide an overview of the results by cluster
of main intervention groupings. For more information
on the complete raw data set, readers are asked to con-
tact the corresponding author.
Interventions aimed at consumers (Additional File 3)
Sixteen publications addressing six unique consumer
interventions provided 17 evidence summaries. Consu-
mer interventions included education/information provi-
sion, decision-making aids, and interventions to support
behavior change. Tables 4, 5, and 6 summarize charac-
teristics of the systematic reviews; Table 7 summarizes
the quality and efficacy appraisals of the interventions;
and Table 8 summarizes the research suggestions made
by members of the team.
The overall quality of the systematic reviews targeting
consumer interventions was variable, ranging from poor
to high. The average AMSTAR score was 7, with scores
ranging from 3 to 10. Most of the systematic reviews did
not include a meta-analysis or an empirical synthesis of
findings. Evidence of effectiveness was most promising
for patient education (e.g., improvements in patient
knowledge and clinical outcomes); decision aids (e.g.,
improvements in patient knowledge and satisfaction,
reduction in patient decisional conflict, and impact on
decisions); and interactive health communication
Brouwers et al. Implementation Science 2011, 6:130
http://www.implementationscience.com/content/6/1/130
Page 3 of 15Table 1 Intervention definitions
Intervention Definition
Consumer interventions
Education interventions informing patients about their treatment and their health (education, information
provision, promotion of health)
Decision aids/shared decision-making
interventions
interventions designed to assist patients make specific and deliberative choices among options by
providing information on the options and outcomes relevant to a person’s health status
Interactive health communication
application (IHCA) interventions
interventions aimed at enabling interactions between an individual and a communication technology
to access or transmit health information, to receive guidance, or to receive support
Contracts a behavioral strategy aimed at improving patient adherence by setting out a set of rules regarding
the behavior of interest and formalizing commitment to adhere to the rules
Reminder packaging interventions aimed to facilitate safe and appropriate medication use (e.g., monitored dose symptoms,
multi-compartment aids)
Multifaceted interventions two or more interventions aimed at assisting patients with adherence to treatment/medications and
improving the prescription process
Professional interventions
Educational outreach and audit and
feedback
interventions whereby a trained person meets with providers in their practice setting to give
information with the goal to change clinical behavior (also referred to as academic detailing) OR any
summary of clinical performance (from health records, observation, computer systems) of healthcare
over a specified time that may also include recommendations for clinical action
Clinical decision support systems (IT/IM/
informatics)
information system interventions that provide the clinician with decision support, including critical
clinical data, reminders, advice on drug or care provision, etc.
Computerized physician order entry (IT/IM/
informatics)
computer-based systems for ordering medications with automated aspects to the ordering process,
such as a list of possible medications for a physician to choose, drug interaction or contraindication
prompts, reminders, etc.
Tracker/reminder systems (IT/IM/informatics) specific interventions that prompt healthcare providers with information specific to the patient or the
encounter that would advise on action to do or action to avoid (interventions can be verbal, paper,
or electronic)
Local opinion leaders educational leaders and influentials nominated by their colleagues
Tailored interventions identify barriers to change and subsequent design of an intervention that addresses identified barriers
Clinical pathways document-based tools that provide a link between best available evidence and clinical practice by
providing recommendations, processes, and time-frames for the management of specific medical
conditions or interventions
Guidelines for professions allied to medicine a systematic statement aimed at assisting in decisions by providers and patients for a specific clinical
condition
Discharge planning from hospital to home interventions aimed at providing individualized plans as a patient is moved from hospital to home
Organizational interventions
Changing length of consultation interventions designed to increase consult time between primary care provider and patient
Routine standard assessment interventions interventions designed to improve the assessment and documentation of patients (akin to pathology
checklist concept in Ontario or surgical checklist concept in various provinces)
Chronic care model interventions interventions aimed at redesigning ambulatory care by modifying elements of the chronic care
model (elements include self-management support, decision support, delivery system design, clinical
information systems, healthcare organizations, and community resources)
Shared-care interventions any type of structured system that involves continuing collaborative clinical care between primary
care and specialty care in the management of patients
Shared-care tactic interventions tactics aimed to facilitate information sharing between providers who provide care to a patient;
include (i) liaison meetings–meetings between specialists and primary care teams whereby ongoing
management of patients within the service is planned and discussed, (ii) shared-care record cards–a
formal information-sharing arrangement where a set of data is agreed to, entered onto a record card,
and usually carried by the patient, or (iii) computer-assisted shared care/email–a formal information-
sharing arrangement whereby a data set is agreed to, entered onto a record card, and shared
between two sectors on computer (can also include coordinated computer registration and patient
recall)
Health information technology interventions switching the format or structure of the medical record, such as computerized medical records
IT = information technology; IM = information management.
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port, behavior, and clinical outcomes). Most reviews
within a given intervention type yielded significant varia-
bility with respect to effectiveness, and most authors
were unable to provide definitive conclusions to their use.
Assessments by research team members on effective-
ness yielded overall mean scores (across evidence sum-
maries of similar interventions) ranging between 3.8 and
6.0 (see “Team Ratings” column of Table 7). Only one,
interactive health communication applications, was rated
as being effective. The remaining interventions were
rated as promising and candidates for more study. Eight
research ideas and three systematic review topics were
identified by members of the research team (Table 8).
Interventions aimed at professionals (Additional File 4)
Twelve publications addressing seven unique profes-
sional interventions provided 14 evidence summaries.
Professional interventions included education, audit and
feedback, information technology (IT)/information man-
agement (IM)/informatics, clinical decision support sys-
tems, computerized physician order entry, reminders,
local opinion leaders, tailored interventions, clinical
pathways, guidelines, and discharge planning. Tables 4,
5, and 9 summarize characteristics of the systematic
reviews; Table 10 summarizes the quality and efficacy
appraisals for the interventions; and Table 11 sum-
marizes the research suggestions made by members of
the research team.
For these systematic reviews, the average AMSTAR score
w a s6 ,w i t hs c o r e sr a n g i n gf r o m3t o8 .T r i a l st h a tc o m -
prised the reviews included RCTs, clinical controlled trials,
pre-/post studies, cluster RCTs, time series, observational,
and trials labeled as “other.” Of the 14 evidence summaries,
4 undertook quantitative pooling (i.e., meta-analysis).
Evidence of effectiveness was most promising for edu-
cational outreach and audit and feedback interventions
(median improvement in clinical outcomes 5%); clinical
decision support (improved clinical performance); com-
puter order entry (reduction in medical errors); clinical
pathways (reduction in complication rates); local opi-
nion leaders (reduction in clinician noncompliance); and
tailored interventions (improvement in some clinical
outcomes). However, these benefits are contrasted
against the concerns with the overall quality and lack of
consistency across the systematic reviews. Moreover, the
primary studies included in the systematic reviews are
reported to be of poor quality, heterogeneous, and
poorly reported with respect to the interventions, con-
texts, and measurements of outcomes. Together, this
makes definitive conclusions about professional inter-
ventions very challenging.
Table 2 Systematic reviews: Stage in continuum of cancer care and implementation intervention cluster
Cluster Continuum-of-care stage
Prevention Screening Diagnosis Treatment Survivorship Follow-up Supportive care Palliative end-of-life care
Professional 5 7 7 10 1 2 2 2
Consumer 4 2 8 16 1 3 8 4
Organizational 1 3 6 8 1 3 4 3
Financial 0 0 0 0 0 0 0 0
Regulatory 0 0 0 0 0 0 0 0
Table 3 Systematic reviews: Cancer diagnosis and implementation intervention cluster
Cluster
Professional Consumer Organizational Financial Regulatory
Breast 4 9 4 0 0
Gastrointestinal 2 2 2 0 0
Genitourinary 2 4 2 0 0
Gynecological 1 1 1 0 0
Head and neck 0 2 0 0 0
Diagnosis Hematologic 1 2 1 0 0
Lung 0 3 0 0 0
Melanoma 1 1 1 0 0
Neuro-oncology 0 0 0 0 0
Sarcoma 1 0 1 0 0
Not specified 5 6 5 0 0
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assessed, and the overall mean scores (across evidence
summaries of the same intervention) ranged between
4.3 and 5.0 all were within the “promising” category (see
“Team Ratings” column in Table 10). Twenty-eight
research ideas were recommended by members of the
research team (see Table 11).
Interventions aimed at organizations (Additional File 5)
Nine reports addressing six unique organizational inter-
ventions provided 10 evidence summaries. The interven-
tions included organizational/structural specific,
continuity-of-care related, shared-care tactics, revisions
of professional roles, and health information technology.
Tables 4, 5, and 12 summarize characteristics of the sys-
tematic reviews; Table 13 summarizes the quality and
efficacy appraisals of the interventions; and Table 14
summarizes the research suggestions made by members
of the team.
Organizational interventions are those aimed at
encouraging use and uptake of knowledge at the organi-
zational level. The average AMSTAR score was 5, with
scores ranging from 2 to 8, which indicates the range of
very poor methodological quality to moderately high
methodological quality. Overall, the reviews were not
able to provide definite conclusions (e.g., statistically sig-
nificant findings) to support the use of any of the speci-
fic interventions reviewed.
Two of the interventions, changing length of consulta-
tion time and shared-care tactic interventions, were
rated by members of the research team as not effective
(ratings of 3 and under). The remaining interventions
fell between 4 and 5 on the scale, indicating promise
and are candidates for further study (see Table 13).
Table 4 Characteristics of systematic reviews
Type of intervention (number of evidence summaries) Theory/framework Study designs included Outcomes included
Y N NS RCT only Non-RCT only Mixed C BO BI K A S
Consumer interventions
Patient education/patient information (n = 8) 2 0 6 2 0 6 4 3 6 6 4 5
Decision aids/shared decision making (n = 5) 2 2 1 0 0 5 1 3 2 4 1 3
Interactive health communication applications (n = 1) 0 0 1 1 0 0 1 1 0 1 0 0
Contracts (n = 1) 1 0 0 1 0 0 0 1 0 1 0 1
Reminder packaging (n = 1) 0 0 1 1 0 0 0 1 0 0 1 0
Multifaceted (n = 1) 0 0 1 1 0 0 1 1 0 0 0 0
Overall 5 2 10 6 0 11 7 10 8 12 6 9
Professional interventions
Educational outreach visits & audit and feedback (n = 4) 1 2 1 2 1 1 4 2 0 2 0 1
IT/IM/informatic interventions (n = 5) 0 1 4 0 1 4 4 5 0 0 0 0
Local opinion leaders (n = 1) 0 0 1 1 0 0 0 1 0 0 0 0
Tailored interventions (n = 1) 1 0 0 1 0 0 1 0 0 0 0 0
Clinical pathway interventions (n = 1) –– – 00 1 1 1 0 0 0 0
Guidelines for professions allied to medicine (n = 1) –– – 00 1 0 1 0 0 0 0
Discharge planning from hospital to home (n = 1) –– – 10 0 1 0 0 0 0 1
Overall 2 3 6 5 2 7 11 10 0 2 0 2
Organizational interventions
Changing length of consultation (n = 1) 0 0 1 0 0 1 1 1 0 0 0 1
Routine standardized assessment (n = 1) 0 0 1 0 0 1 1 1 0 1 1 1
Chronic care model interventions (n = 1) 1 0 0 0 0 1 0 1 0 0 0 0
Models-of-care/integrated care-related interventions (n = 5) 0 2 3 0 2 3 4 2 1 3 1 3
Shared-care tactic interventions (n = 1) 0 1 0 0 0 1 1 1 0 0 0 1
Health information technology (n = 1) 1 0 0 0 0 1 1 1 0 0 0 1
Overall 2 3 5 0 2 8 8 7 1 4 2 7
Y = yes; N = no; NS = not specified; RCT = randomized controlled trial; C = clinical; BO = behaviour observed; BI = behaviour intention; K = knowledge; A =
attitudes; S = satisfaction; IT = information technology; IM = information management.
Note: The reviews added post-hoc (Rotter, 2010; Shepperd, 2010; Thomas, 2009) did not have full data extraction completed; this is indicated by cells with “–”.
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Type of intervention (number of evidence summaries) Context: Who delivered Context: Where
delivered
Context: How delivered
Pt Fam Clin Ad PH O Home Comm ClE O Per Paper Phone TI TS NS
Consumer interventions
Patient education/patient information (n = 8) 0 0 5 0 0 3 4 3 7 4 4 7 4 2 2 0
Decision aids/shared decision making (n = 5) 0 0 5 0 0 0 2 0 3 2 2 5 1 4 2 0
Interactive health communication applications (n = 1) 0 0 0 0 0 1 1 1 1 0 1 1 0 1 1 0
Contracts (n = 1) 0 0 1 0 0 0 1 0 1 0 1 1 0 0 0 0
Reminder packaging (n = 1) 1 1 1 0 0 1 1 1 1 1 1 0 0 0 1 0
Multifaceted (n = 1) 1 1 1 0 0 1 1 1 1 1 1 1 1 1 1 0
Overall 2 2 13 0 0 6 10 6 14 8 10 15 6 8 7 0
Professional interventions
Educational outreach visits & audit and feedback (n = 4) 0 0 3 1 0 2 0 1 4 1 4 4 3 2 1 0
IT/IM/informatic interventions (n = 5) 0 0 2 1 0 4 0 2 5 1 0 0 0 4 1 0
Local opinion leaders (n = 1) 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0
Tailored interventions (n = 1) 0 0 0 0 0 1 0 1 1 0 0 0 0 0 0 1
Clinical pathway interventions (n = 1) 0 0 1 0 0 0 –– – – – –– – – –
Guidelines for professions allied to medicine (n = 1) 0 0 1 0 0 0 –– – – – –– – – –
Discharge planning from hospital to home (n = 1) 0 0 1 0 0 0 –– – – – –– – – –
Overall 0 0 9 2 0 7 0 4 11 2 5 4 3 6 2 1
Organizational interventions
Changing length of consultation (n = 1) 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0
Routine standardized assessment (n = 1) 0 0 1 0 0 1 0 0 1 0 1 1 0 0 0 0
Chronic care model interventions (n = 1) 0 0 1 0 0 1 0 1 1 0 1 0 0 0 0 1
Models-of-care/integrated care-related interventions (n =
5)
00 500 0 1 2 5 1 5 4 2 2 0 0
Shared-care tactic interventions (n = 1) 0 0 1 0 0 0 1 1 1 1 1 1 1 1 0 0
Health information technology (n = 1) 0 0 1 1 0 0 0 0 1 0 0 0 0 1 0 0
Overall 0 0 10 1 0 2 2 4 10 2 9 6 3 4 0 1
Pt = patients; Fam = family; Clin = clinicians; Ad = administrator/manager; PH = public health; O = other; Comm = community; ClE = clinical environment; Per =
person; TI = technology–interactive; TS = technology–static; NS = not specified; IT = information technology; IM = information management.
Note: The reviews added post-hoc (Rotter, 2010; Shepperd, 2010; Thomas, 2009) did not have full data extraction completed; this is indicated by cells with “–”.
Table 6 Consumer-focused interventions: Number of systematic reviews for each cluster
Type of intervention Total number of
SRs
Number of SRs–cancer
only
Number of SRs–
mixed
Number of SRs– no
cancer
Patient education and patient information 84 4 0
Patient decision aids 53 2 0
Interactive health communication
applications
10 1 0
Contracts 10 0 1
Reminder packaging 10 0 1
Multifaceted 10 1 0
SR = systematic review.
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Page 7 of 15Table 7 Consumer interventions: Appraisal of systematic review (AMSTAR) scores and intervention effectiveness
ratings by research team
Intervention cluster and systematic review first author (year) Scores and ratings
AMSTAR (1 to 11) Research team ratings
Mean SD
Patient education/patient information
Bennett (2009) [26] 8 5.7 0.67
Gaston (2005a) [35] 5 4.7 0.45
Gysels (2007) [37] 5 3.0 1.00
Goldberg (2007a) [36] 3 3.8 0.45
Wofford (2005) [56] 7 4.3 0.84
Santo (2005) [47] 7 4.6 0.89
Conn (2008) [30] 10 4.3 1.79
Raynor (2007) [45] 8 4.0 0.71
Overall mean score 7 4.3
Patient decision aids
Evans (2005) [33] 7 4.4 1.14
Gaston (2005b) [35] 5 4.3 0.97
Waljee (2007) [54] 8 6.1 0.22
Edwards (2008) [32] 5 3.8 0.45
Joosten (2008) [41] 5 5.1 0.22
Overall mean score 6 4.7
Interactive health communication applications
Murray (2005) [43] 11 6 1
Contracts
Bosch-Capblanch (2007) [27] 9 3.8 0.84
Reminder packaging
Heneghan (2006) [39] 10 5.1 0.74
Multifaceted
Haynes (2008) [38] 10 4.6 0.89
Table 8 Consumer interventions: Nominated research ideas
Type of intervention Research ideas
Patient education/patient information Randomized studies directly comparing different intervention formats/modalities/techniques on satisfaction,
adherence, and clinical outcomes (prioritize those interventions from which individual studies have shown
greatest promise on clinical outcomes) (i.e., how to do it)
Decision aids Development, testing, and evaluation of cancer decision aids in understudied areas (e.g., role within
personalized medicine, molecular-genetics) ￿
Development, testing, and evaluation of cancer decision aids in understudied populations
Interactive health communication
applications (IHCA)
What are the implications for IHCA on privacy policies and legislations?
Contract interventions Outside of cancer prevention, no role
Reminder packaging Research to identify if adherence to medication protocols is a problem for cancer patients (e.g., for which
drugs, cancer diagnoses, complexity of drug regimen) ￿
Generalize to other aspects of cancer care–What are effective strategies to remind cancer survivors of
follow-up and monitoring regimens? (linked to discharge plan priorities)
Multifaceted intervention Design and evaluate multifaceted consumer interventions for specific cancer control problems using Haynes
et al. review as foundation (i.e., deconstruct systematic review to identify most promising intervention
clusters for specific contexts)
Systematic review priorities Acquiring skills and competencies ￿
Consumer system participation ￿
Minimizing risks or harms
Brouwers et al. Implementation Science 2011, 6:130
http://www.implementationscience.com/content/6/1/130
Page 8 of 15Twenty-eight research ideas were recommended by
members of the research team (see Table 14).
Conclusion
We considered 34 unique systematic reviews providing 41
evidence summaries for 19 KT interventions. The quality of
the execution of the systematic reviews varied significantly,
with AMSTAR ratings ranging between 2 and 10. Primary
evidence serving as the foundation for the systematic
reviews included RCTs and nonrandomized trials. Systema-
tic review authors describe the primary evidence as uneven
with respect to quality, reporting, and outcomes.
While many interventions suggested promise of effec-
tiveness, few reviews were able to conclude definitively
Table 9 Professional-focused interventions: Number of systematic reviews for each cluster
Type of intervention Total number of
SRs
Number of SRs–cancer
only
Number of SRs–
mixed
Number of SRs– no
cancer
Educational outreach visits & audit and
feedback
42 2 0
IT/IM/informatics 51 4 0
Local opinion leaders 10 1 0
Tailored interventions 10 0 1
Clinical pathways 10 1 0
Guidelines for professions allied to
medicine
10 1 0
Discharge planning from hospital to home 10 1 0
SR = systematic review; IT = information technology; IM = information management.
Table 10 Professional interventions: Appraisal of systematic review (AMSTAR) scores and intervention effectiveness
ratings by research team
Intervention cluster and systematic review first author (year) Scores and ratings
AMSTAR (1 to 11) Research team ratings
Mean SD
Educational outreach visit & audit and feedback interventions
Goldberg (2007b) [36] 3 4.6 0.89
O’Brien (2007) [44] 8 4.8 1.17
Goldberg (2007c) [36] 3 3.8 0.98
Jamtvedt (2006) [40] 8 4.7 0.82
Overall mean score 5.5 4.5
IT/IM/informatic interventions
Goldberg (2007d) [36] 3 3.7 0.52
Garg (2005) [34] 5 5.3 0.52
Ammenwerth (2008) [23] 6 5.7 0.52
Beach (2006a) [25] 5 5.7 1.03
Shojania (2009) [50] 8 4.7 0.52
Overall mean score 5.4 5.0
Local opinion leader interventions
Doumit (2007) [31] 7 4.3 0.82
Tailored interventions
Baker (2010) [24] 7 4.8 1.47
Clinical pathway interventions
Rotter (2010)
a [46] – NA NA
Guidelines for professions allied to medicine
Thomas (2009)
a [53] – NA NA
Discharge planning from hospital to home
Shepperd (2010)
a [49] – NA NA
aThese reviews were included post hoc, identified by members of the research team.
IT = information technology; IM = information management.
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Type of intervention Research ideas
Educational outreach visits (EOV)/audit
and feedback (AF)
Better quality trials directly evaluating specific modalities and methods of EOV (proper randomization,
baseline data, variety of outcomes–including patient outcomes and costing)
Better quality trials directly evaluating specific modalities and methods of methods of AF (as above)
For which clinicians, clinical conditions, and stage in the continuum is EOV most impactful?
For which clinicians, clinical conditions, and stage in the continuum is AF most impactful?
What is the impact of regional AF versus individual AF on changing patterns of practice?
IT/IM/informatic interventions Better quality trials directly evaluating specific modalities and methods of informatic interventions (proper
randomization
For which clinicians, clinical conditions, and stage in the continuum are informatics interventions most
impactful?
Develop methods to enable practice guidelines to be directly integrated into informatic interventions
What is the cost effectiveness of different informatic interventions?
Are informatic interventions effective in non-drug-prescribing aspects of cancer care?
Local opinion leader interventions Methodological development in choosing local opinion leaders in a reliable manner
Methodological development in understanding factors that increase and decrease sustainability of local
opinion leader designation
Research to better understand for which provider groups and under what clinical contexts (cancer
diagnosis, practice setting, stage of the cancer trajectory) local opinion leaders are most effective
Tailored interventions Methodological analysis of the operational techniques of tailoring in existing high-quality primary studies
Methodological development to determine when tailoring has or has not addressed identified barriers
Identification of defining factors of effective tailoring
Direct comparisons of different tailoring interventions (tactic and modality, etc.) on uptake of evidence,
processes of care, and clinical outcomes
Clinical pathway interventions Testing of clinical pathway interventions on different stages of continuum of cancer care
Testing of clinical pathway interventions with different healthcare providers involved in cancer control
Methodological development to determine for which clinical problem (e.g., cancer diagnosis, complexity
of care) clinical pathways are most effective
Direct comparisons of different clinical pathway strategies (methods and modality, etc.) on uptake of
evidence, processes of care, and clinical outcomes
Is the introduction of clinical pathways cost effective in Ontario/Canada?
Guidelines Compare and contrast use of and impact of guidelines on processes of care and clinical outcome as a
function of cancer care provider
Testing innovative strategies to disseminate guideline messages to different providers
Testing of innovative strategies to disseminate guideline messages to administrators
Testing of innovate strategies to disseminate guideline messages to policy makers
Discharge planning What are the defining features/components to a discharge plan that are linked to patient satisfaction,
provider satisfaction, process outcomes, and clinical outcomes?
Determining the specific clinical components for discharge plans for different cancer diagnoses
IT = information technology; IM = information management.
Table 12 Organizational-focused interventions: Number of systematic reviews for each cluster
Type of intervention Total number of
SRs
Number of SRs–cancer
only
Number of SRs– cancer
included
Number of SRs– no
cancer
Changing length of
consultation
10 0 1
Routine standard assessment 11 0 0
Chronic care model 10 1 0
Models of care/integrated
care
52 3 0
Shared-care tactic 10 1 0
Health information
technology
10 1 0
SR = systematic review.
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Page 10 of 15in favor of or against a specific intervention. The inter-
pretation of the evidence by members of the research
team aligned with this analysis. The majority of the
interventions were rated by the research team members
as promising, but in need of additional study.
In considering KT in cancer control, one is struck by
the complexity of the enterprise. While there are many
studies being conducted, the quality is decidedly uneven
and the impact on patient care or system performance
is questionable. To that end, some key observations are
noted and conclusions for the research enterprise can
be drawn.
Overall, the approach to KT in cancer control appears
patchy and unsystematic. While this may be due, in
part, to the breadth, size, and scope of the research area,
it is likely to be a major contributor to the hodgepodge
of studies being conducted, the failure of the research
community to consistently embrace high-quality
research paradigms and standards, and the inability to
create a common language and taxonomy in the field.
Indeed, common across the systematic reviews consid-
ered here is that the studies that underpin them often
fail to adequately describe all aspects of the KT inter-
vention under investigation and (where relevant) the
control group. This makes it very difficult to synthesize
data, to improve the overall research enterprise, and to
build from one study to another. Here, work by
Cochrane’s EPOC group and researchers such as Michie
and others may assist in designing a common language,
a common set of operational definitions, and common
labels to facilitate the advancement of the KT field
[20-22].
The complexity of the cancer field and the impact of
that complexity to the KT research agenda cannot be
underestimated. The numerous but unique diagnoses,
the variety of providers involved in cancer care and con-
trol (i.e., public health, primary care, medical specialists,
allied health providers, lay and peer providers), the var-
ious organizational settings in which care is offered, the
risks associated with some careo p t i o n s ,a n dt h ev a r i a -
bility in decision-making styles by individuals affected
by cancer are examples of this complexity. As it relates
to the KT research enterprise, the role of context and
individual differences must be stressed.
The design and execution of the primary studies fall
below acceptable levels of quality. For example, we
found that the systematic reviews often fail to measure
meaningful end points because these data are not avail-
able in the primary literature that comprise the eviden-
tiary base for synthesis. While measures of knowledge,
satisfaction, and intention are important–and in fact,
better studied–measures of intervention fidelity (or
adherence to intervention), relevant clinical end points,
and valid patient-centered outcomes are often lacking.
In addition, the design and execution of the systematic
reviews in the KT field are uneven. For example, use of
factorial designs, multilevel modeling techniques, and
regression strategies could improve the precision by
Table 13 Organizational-focused interventions: Appraisal of systematic review (AMSTAR) scores and intervention
effectiveness ratings by research team
Intervention cluster and relevant systematic review first author (year) Scores and ratings
AMSTAR (1 to 11) Research team ratings
Mean SD
Changing length of consultation interventions
Wilson (2006) [55] 7 3 0.71
Routine standard assessment interventions
Goldberg (2007e) [36] 3 3.8 1.30
Chronic care model interventions
Coleman (2009) [29] 2 4.4 0.55
Models-of-care/integrated care-related interventions
Lewis (2009) [42] 7 3.8 1.10
Smith (2008) [52] 8 3.2 1.30
Beach (2006b) [25] 5 4.6 0.89
Goldberg (2007f) [36] 3 3.6 0.89
Scheuner (2008) [48] 4 2.6 0.55
Overall mean score 5.4 3.6
Shared-care tactic interventions
Smith (2007) [51] 8 3 1.22
Health information technology interventions
Chaudhry (2006) [28] 4 4.6 0.89
Brouwers et al. Implementation Science 2011, 6:130
http://www.implementationscience.com/content/6/1/130
Page 11 of 15Table 14 Organizational interventions: Nominated research ideas
Type of intervention Research ideas
Changing length of consultation Does length of consultation influence patient satisfaction, clinician satisfaction, or patient outcomes in a
clinical context?
Modeling the clinical encounter to predict patient satisfaction, clinician satisfaction, and patient outcomes.
Use length of consult time as one of the predictors (examples of others: types of information shared, type of
clinician, diagnosis).
In what stages of the cancer continuum does the length of consultation impact patient satisfaction, clinician
satisfaction, and patient outcomes?
What is the cost effectiveness of longer consultation times?
Routine assessment interventions Conduct a high-quality systematic review examining the impact of routine standard assessment (across cancer
care continuum) on delivery of cancer care, satisfaction (patient and clinician), and clinical outcomes
What is the impact of routine standard assessment on other aspects of cancer care other than pain?
Conduct a well-designed randomized trial to evaluate the impact of routine standard assessments on delivery
of care (fidelity), satisfaction of care (patient and clinician), and clinical outcomes
Compare and contrast methods used to determine and create tools to support implementation of routine
standard assessments to ensure they are based on evidence and acceptable to clinicians and patients
Research examining how to implement routine standard assessments into an oncology practice setting
(ambulatory or in-patient) so that it is acceptable (to management, clinicians, patients), effective, and cost
effective
Chronic care model (CMM)
interventions
Conduct a high-quality systematic review examining the impact of CMM on delivery of cancer control,
satisfaction (patient, clinician, policy), and clinical outcomes
Research (qualitative and/or scoping review) to assess whether CCM applies well to the cancer control
context. Which components of the CCM (if any) are most relevant to cancer control? Which aspect of cancer
control (e.g., diagnosis) lends itself to the CCM model?
Design, evaluate, and refine tools to support each of the six CCM components using high-quality methods
Models of care/integrated care
interventions 1
Research to better understand for what cancer diagnoses, cancer care options, stages in the continuum, and
contexts (e.g., geography) are different models of care and integration of services most appropriate (e.g.,
systematic review, case study intervention)
High-quality economic analysis comparing different models of care
Research aimed to analyze (and perhaps statistically model) existing models of care to better understand the
mechanisms underlying the processes and the outcomes of different approaches
Deconstruction of existing systematic reviews to better understand the mechanisms underlying different
models of care
Develop methods to better measure the concepts of shared care and integrated care
Models of care/integrated care
interventions 2
Development/identification, implementation, and evaluation (process, satisfaction, patient outcomes) of
various models (care and service) aimed at the diagnostic stage of continuum and transition to treatment (e.
g., systemic review, scoping review, or randomized trial)
As above but focused on treatment only (e.g., systematic review or scoping review)
As above but aimed at the treatment stage of the continuum and transition to survivorship or palliative care
How to best introduce new models of care or new clinical roles into the care system
Research aimed to test effectiveness, safety, satisfaction (patient, providers, and system) and cost effectiveness
of new clinical roles in cancer control by non-medical clinical professionals
Shared-care implementation tactic
interventions
Using high-quality randomized methods, compare and contrast different existing tactics aimed to facilitate
communication between healthcare providers
Develop, test, and refine new tactics aimed at facilitating communication between different practitioners
Health information technology (HIT)
interventions
What are the most effective and efficient strategies to implement an HIT solution?
For what cancer-control contexts (e.g., continuum of care, diagnosis, practice setting) is an HIT solution most
appropriate?
Does embedding evidence-based recommendations into the HIT solutions improve quality of care over HIT
solutions alone?
Are HIT solutions cost effective?
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Page 12 of 15which we understand KT interventions. The application
of these techniques is warranted. While this has been
undertaken in some of the systematic reviews, it is not
consistent, nor is it being done in the primary studies
underpinning the existing reviews.
Thus, common principles of good scholarship and
methodological rigor are required in systematic reviews
of KT research and in the primary studies that underpin
them. Namely, well-defined research questions, appro-
priate research design, patient-centered outcomes, analy-
tic strategies to better understand the mechanisms
associated with change, and completeness of reporting
are necessary.
There are, however, limitations to our study. First, to
manage scope and resource constraints of the project,
we considered only systematic reviews available in data-
bases of systematic reviews. While trying to avoid dupli-
cation, we acknowledge there may be other reviews that
would have met our inclusion criteria that were not
included in any of the three databases. Further, one
review by Grimshaw (2006) [19] was found to be eligible
during our search but was erroneously deleted and not
included in our review. In addition, we acknowledge
that there are likely primary studies not yet included in
any of the systematic reviews we considered that would
have been relevant to our question.
Second, this study was Canadian in focus with respect
to members of the research team. While this conformed
to the request for proposals criteria of the project’sf u n -
ders, it may be that a different composition of indivi-
duals would have yielded different conclusions. To
advance the field, gathering a more international per-
spective may be warranted.
In summary, this project provides an overview of the
evidence related to KT in cancer control. Given the cur-
rent state of the evidence and the need for additional
research in so many areas, we were not able to offer a
definitive blueprint outlining a small manageable set of
research priorities in this context. The field is open and
considerable work is required. To ensure world-class
research and research that will have a positive impact
on people with cancer and on cancer system perfor-
mance requires clarity and transparency of research
scope and goals coupled with high expectations for the
research community to achieve excellence in study
design, execution, and reporting.
Endnotes
aInterventions to influence uptake of cancer screening
were explored in a separate project and were not con-
sidered here [17]. Cancer prevention was out of scope
for this project and the aforementioned project.
bO n ee l i g i b l es y s t e m a t i cr e v i e wb yG r i m s h a wet al.
(2006) was inadvertently deleted from the systematic
review sample [19]. It focused on guidance dissemina-
tion and implementation strategies. They found absolute
improvement in performance of 14.1% for reminders,
8.1% for dissemination, 7.0% for audit and feedback, and
6% for multifaceted interventions. This review is not
included in the summary statistics presented.
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